Peter Dudek is a President & Managing Partner, MRL Ventures Fund at Merck, whose known portfolio counts 27 companies.
Is Peter Dudek a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcare
Contacts
Affiliated funds' portfolios
President & Managing Partner, MRL Ventures Fund at Merck, whose known portfolio counts 27 companies
- Mosaic
- Octave
- Artios Pharma
- Unnatural Products
- Formo
- Ambrosia Biosciences
- Atropos Health
- PreciseDx
- Moderna
- Aktis Oncology
- Orna Therapeutics
- Variational AI
- and 15 more
Investor Profile
The listing covers sectors AI and Healthcare, and focus areas AI Applications, Biotech, Diagnostics and Drug Discovery. Startups operating in these areas may find Peter Dudek relevant.
Stage-wise, the deals at Merck cluster around Growth, Late-Stage and Seed rounds.
The firm portfolio and the focus above give founders context on whether Peter Dudek matches their raise.
Colleagues at Merck
Joe Volpe
Managing Director
Hatfield, United States
Olga Danilchanka
Partner, MRL Ventures Fund
Cambridge, United States
Tao Fang
Investor
Boston, United States
Harry Arader
President
St Louis, United States
Neil Strotman
Director, Oral Formulations Science
Metuchen, United States
William Taranto
President
New Hope, United States
Tony Martinez
Investor
Lambertville, United States
Sammie Irwin
Investor
O'Fallon, United States
Pan Fsa
Venture Capital & Private Equity Professional
India
Frequently asked questions
Who is Peter Dudek?
Peter Dudek is a corporate venture investor based in Cambridge, Massachusetts, United States, listed as President & Managing Partner, MRL Ventures Fund at Merck. The known portfolio of that firm counts 27 companies. That portfolio belongs to the firm, not to Peter Dudek personally.
What does Peter Dudek invest in?
Listed sectors include AI and Healthcare; listed focus areas include AI Applications, Biotech, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Peter Dudek invest at?
Merck appears in Growth, Late-Stage and Seed rounds across its known deals, and Peter Dudek is listed there as President & Managing Partner, MRL Ventures Fund. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Peter Dudek listed at?
Peter Dudek is listed as President & Managing Partner, MRL Ventures Fund at Merck. 9 other people in the database share a firm with Peter Dudek.
How do I contact Peter Dudek?
An email address, a phone number and a LinkedIn page are on file for Peter Dudek. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal